AMPH  valuation analysis

Basics
Name: Amphastar Pharmaceuticals Inc
Description: Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. (more)
Industry: Drug Manufacturers-Specialty & Generic
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 09, 2022
Market cap: $1.91B (1037th)
Sales(TTM): $455.12M (1265th)
Earnings(TTM): $81.33M (1040th)

Value
FFER: 0.71*
Actual price: $36.72
* Earnings were reported Aug 08, 2022 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Amphastar Pharmaceuticals Inc's earnings grew by 2314.0% ($3.37M to $81.33M) over one year against a market average growth of 177.6%.
Earnings / MarketCap
Amphastar Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry
Sales / MarketCap
Amphastar Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry
Book / MarketCap
Amphastar Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry
Equity / Assets
Amphastar Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry